Indian pharma companies get US FDA nod for schizophrenia drug.
- April 20, 2015
The US drug regulator, US Food & Drug Administration (FDA) has approved the first generic versions of Abilify (compound aripiprazole) used in the treatment of schizophrenia and bipolar disorders. Alembic Pharmaceuticals, Hetero Labs, and Torrent Pharmaceuticals from India and Teva Pharmaceuticals have received US FDA approval to market generic aripiprazole in multiple strengths and dosage